BMS ‘Increasingly Confident’ It Can Handle The Impact Of Medicare Pricing For Eliquis

Pharma To Announce IRA-Mandated Final Price Soon

Jul 26 2024

BMS raised its 2024 revenue guidance based on its Q2 performance • Source: Shutterstock